中国抗癌协会临床肿瘤学协作中心第三届学术年会于10月4日在大连召开,200多位肿瘤专家出席了这一年一度的全国肿瘤界最权威的学术讨论会。会上,90年代突破性的化疗药物泰素得到肿瘤专家的大力推荐。 美国约翰-霍普金斯医学院新加坡分校肿瘤科主任张元吉博士表示:“非小细胞肺癌患者若采用泰素和卡钩联合化疗方案作一线治疗,其总有效率和一年生 The 3rd Annual Conference of Clinical Oncology Collaborating Center of China Anti-Cancer Association was held in Dalian on October 4, with more than 200 oncologists attending this annual national academic conference on the most authoritative oncology. At the meeting, the breakthrough chemotherapeutic drug Taxol in the 90’s was highly recommended by oncologists. The United States Johns Hopkins School of Medicine Singapore Branch Dr. Zhang Yuanji, director of oncology, said: "If non-small cell lung cancer patients with sycamorecept and hook chemotherapy for first-line treatment, the total effective rate and annual